AgomAb Therapeutics NV Rings the Closing Bell

view original post

About This EventAgomAb Therapeutics NV (Nasdaq: AGMB), a clinical-stage biopharmaceutical company focused on developing novel disease-modifying therapies for immunology and inflammatory diseases, with …